Empowering Partners
Advancing Patient Access
We are a trusted European partner for go-to-market and commercialization, helping transform innovation into meaningful patient impact.
Trusted by innovators across Europe
European expertise, global reach
We are headquartered in Copenhagen, Denmark and are the gateway to accessing the European markets.
A complete end-to-end solution enabling rapid and broad patient access to innovative therapies in rare and specialty disease areas
With deep regional expertise, regulatory know-how, and an agile mindset, we bring value to our partners – and life-changing medicines to patients.
Deep market insight
We own unmatched visibility into pricing trends, reimbursement behavior, and real-time market dynamics across all European countries.
European footprint
Physical presence and legal entities in all major European countries - ready to act as marketing authorization holder, distributor, or strategic partner as needed.
Agile go-to-market models
Custom market entry strategies - from centralized EU launches to country-by-country optimization based on value, uptake, and reimbursement potential.
Data-driven commercialization
With extensive databases combined with on-the-ground intelligence, we are capable of doing accurate forecasting, agile decision-making, and adaptive pricing strategies.
Novel therapies
Accelerate launch trajectories
A comprehensive suite of services designed specifically to support the end-to-end commercialisation needs of biotech and pharmaceutical companies with near-to-market products.
Established brands
Optimise multi-market operations
A selection of services to enable secure access to local markets in a time and resource-efficient manner, including multi-market tender and supply chain management.
Ready to take the next step?
Let us share how we could successfully support your product commercialisation.
Therapeutic areas
Future Focus
Genetic & Metabolic Disorders
Haematology & Oncology
Latest insights
Stay abreast of key issues and critical thinking within the European rare disease community.